Drain Placement After Uncomplicated Hepatic Resection Increases Severe Postoperative Complication Rate: A Japanese Multi-institutional Randomized Controlled Trial (ND-trial).


Journal

Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354

Informations de publication

Date de publication:
01 02 2021
Historique:
pubmed: 17 10 2020
medline: 20 2 2021
entrez: 16 10 2020
Statut: ppublish

Résumé

To assess the clinical impact of a no-drain policy after hepatic resection. Previous randomized controlled trials addressing no-drain policy after hepatic resection seem inconclusive because they did not adopt appropriate study design to validate its true clinical impact. This unblinded, randomized controlled trial was done at 7 Japanese institutions. Patients undergoing hepatic resection without biliary reconstruction were randomized to either D group or ND group. When the risk of postoperative bile leakage or hemorrhage were considered high, the patients were excluded during the operation. Primary endpoint was the postoperative complication of C-D grade 3 or higher within 90 postoperative days. A noninferiority of ND group to D group was assessed, and if it was confirmed, a superiority was assessed. Between May 2015 and July 2017, a total of 400 patients were finally included in the per-protocol set analysis: 199 patients in D group and 201 patients in ND group. Intraoperatively, 37 patients were excluded from the final enrollment because of high risk of bile leakage or hemorrhage. Postoperative complication rate of C-D grade 3 or higher was 8.0% (16/199) in the D group and 2.5% (5/201) in the ND group. The risk difference was -5.5% (95% confidence interval: -9.9% to -1.2%) and fulfilled the prescribed noninferiority margin of 4%. No postoperative mortality was experienced in both groups. Bile leakage was diagnosed in 8.0% (16/199) of the D group and none in the ND group (P < 0.001). In none of the subgroups classified based on 8 potentially relevant factors, drain placement was favored in terms of C-D grade 3 or higher complication. Drains should not be placed after uncomplicated hepatic resections.

Sections du résumé

OBJECTIVE
To assess the clinical impact of a no-drain policy after hepatic resection.
SUMMARY OF BACKGROUND DATA
Previous randomized controlled trials addressing no-drain policy after hepatic resection seem inconclusive because they did not adopt appropriate study design to validate its true clinical impact.
METHODS
This unblinded, randomized controlled trial was done at 7 Japanese institutions. Patients undergoing hepatic resection without biliary reconstruction were randomized to either D group or ND group. When the risk of postoperative bile leakage or hemorrhage were considered high, the patients were excluded during the operation. Primary endpoint was the postoperative complication of C-D grade 3 or higher within 90 postoperative days. A noninferiority of ND group to D group was assessed, and if it was confirmed, a superiority was assessed.
RESULTS
Between May 2015 and July 2017, a total of 400 patients were finally included in the per-protocol set analysis: 199 patients in D group and 201 patients in ND group. Intraoperatively, 37 patients were excluded from the final enrollment because of high risk of bile leakage or hemorrhage. Postoperative complication rate of C-D grade 3 or higher was 8.0% (16/199) in the D group and 2.5% (5/201) in the ND group. The risk difference was -5.5% (95% confidence interval: -9.9% to -1.2%) and fulfilled the prescribed noninferiority margin of 4%. No postoperative mortality was experienced in both groups. Bile leakage was diagnosed in 8.0% (16/199) of the D group and none in the ND group (P < 0.001). In none of the subgroups classified based on 8 potentially relevant factors, drain placement was favored in terms of C-D grade 3 or higher complication.
CONCLUSIONS
Drains should not be placed after uncomplicated hepatic resections.

Identifiants

pubmed: 33064385
pii: 00000658-202102000-00008
doi: 10.1097/SLA.0000000000004051
doi:

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

224-231

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Références

Mise Y, Vauthey JN, Zimmitti G, et al. Ninety-day postoperative mortality is a legitimate measure of hepatopancreatobiliary surgical quality. Ann Surg 2015; 262:1071–1078.
Shirata C, Kokudo T, Arita J, et al. Albumin-Indocyanine Green Evaluation (ALICE) grade combined with portal hypertension to predict posthepatectomy liver failure. Hepatol Res 2019; 49:942–949.
Hanks JB, Meyers WC, Filston HC, et al. Surgical resection for benign and malignant liver disease. Ann Surg 1980; 191:584–592.
Didolkar MS, Fitzpatrick JL, Elias EG, et al. Risk factors before hepatectomy, hepatic function after hepatectomy and computed tomographic changes as indicators of mortality from hepatic failure. Surg Gynecol Obstet 1989; 169:17–26.
Merad F, Hay JM, Fingerhut A, et al. Is prophylactic pelvic drainage useful after elective rectal or anal anastomosis? A multicenter controlled randomized trial. French Association for Surgical Research. Surgery 1999; 125:529–535.
Belghiti J, Kabbej M, Sauvanet A, et al. Drainage after elective hepatic resection. A randomized trial. Ann Surg 1993; 218:748–753.
Fong Y, Brennan MF, Brown K, et al. Drainage is unnecessary after elective liver resection. Am J Surg 1996; 171:158–162.
Liu CL, Fan ST, Lo CM, et al. Abdominal drainage after hepatic resection is contraindicated in patients with chronic liver diseases. Ann Surg 2004; 239:194–201.
Fuster J, Llovet JM, Garcia-Valdecasas JC, et al. Abdominal drainage after liver resection for hepatocellular carcinoma in cirrhotic patients: a randomized controlled study. Hepatogastroenterology 2004; 51:536–540.
Sun HC, Qin LX, Lu L, et al. Randomized clinical trial of the effects of abdominal drainage after elective hepatectomy using the crushing clamp method. Br J Surg 2006; 93:422–426.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240:205–213.
Fischer L, Seiler CM, Broelsch CE, et al. Hemostatic efficacy of TachoSil in liver resection compared with argon beam coagulator treatment: an open, randomized, prospective, multicenter, parallel-group trial. Surgery 2011; 149:48–55.
Hahn O, Blazovics A, Vali L, et al. The effect of ischemic preconditioning on redox status during liver resections--randomized controlled trial. J Surg Oncol 2011; 104:647–653.
Rahbari NN, Elbers H, Koch M, et al. Randomized clinical trial of stapler versus clamp-crushing transection in elective liver resection. Br J Surg 2014; 101:200–207.
van den Broek MA, Bloemen JG, Dello SA, et al. Randomized controlled trial analyzing the effect of 15 or 30 min intermittent Pringle maneuver on hepatocellular damage during liver surgery. J Hepatol 2011; 55:337–345.
Capussotti L, Ferrero A, Russolillo N, et al. Routine anterior approach during right hepatectomy: results of a prospective randomised controlled trial. J Gastrointest Surg 2012; 16:1324–1332.
Doklestic K, Karamarkovic A, Stefanovic B, et al. The efficacy of three transection techniques of the liver resection: a randomized clinical trial. Hepatogastroenterology 2012; 59:1501–1506.
Jones C, Kelliher L, Dickinson M, et al. Randomized clinical trial on enhanced recovery versus standard care following open liver resection. Br J Surg 2013; 100:1015–1024.
Gotohda N, Yamanaka T, Saiura A, et al. Impact of energy devices during liver parenchymal transection: a multicenter randomized controlled trial. World J Surg 2015; 39:1543–1549.
Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975; 31:103–115.
Couinaud C. Couinaud C. Les hepatectomies elargies. Masson, Le Foie: Etudes Anatomiques et Chirurgicales . Paris: 1957.
Japan Clinical Oncology Group. JCOG postoperative complication criteria according to Clavien-Dindo Classification ver2.0. Available at: http://www.jcog.jp/doctor/tool/JCOG_Clavien-Dindo_ver2.0.pdf . Accessed February 1, 2019
Koch M, Garden OJ, Padbury R, et al. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery 2011; 149:680–688.
Slankamenac K, Graf R, Barkun J, et al. The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg 2013; 258:1–7.
Dunnett CW, Gent M. Significance testing to establish equivalence between treatments, with special reference to data in the form of 2X2 tables. Biometrics 1977; 33:593–602.
Petrowsky H, Demartines N, Rousson V, et al. Evidence-based value of prophylactic drainage in gastrointestinal surgery: a systematic review and meta-analyses. Ann Surg 2004; 240:1074–1084.
Gavriilidis P, Hidalgo E, de’Angelis N, et al. Re-appraisal of prophylactic drainage in uncomplicated liver resections: a systematic review and meta-analysis. HPB (Oxford) 2017; 19:16–20.
Tanaka K, Kumamoto T, Nojiri K, et al. The effectiveness and appropriate management of abdominal drains in patients undergoing elective liver resection: a retrospective analysis and prospective case series. Surg Today 2013; 43:372–380.
Drinkwater CJ, Neil MJ. Optimal timing of wound drain removal following total joint arthroplasty. J Arthroplasty 1995; 10:185–189.
Brooke-Smith M, Figueras J, Ullah S, et al. Prospective evaluation of the International Study Group for Liver Surgery definition of bile leak after a liver resection and the role of routine operative drainage: an international multicentre study. HPB (Oxford) 2015; 17:46–51.
Fischer JE. A cautionary note: the use of vacuum-assisted closure systems in the treatment of gastrointestinal cutaneous fistula may be associated with higher mortality from subsequent fistula development. Am J Surg 2008; 196:1–2.
Bekki Y, Yamashita Y, Itoh S, et al. Predictors of the effectiveness of prophylactic drains after hepatic resection. World J Surg 2015; 39:2543–2549.
Hokuto D, Nomi T, Yasuda S, et al. The safety of the early removal of prophylactic drainage after liver resection based solely on predetermined criteria: a propensity score analysis. HPB (Oxford) 2017; 19:359–364.
Mitsuka Y, Yamazaki S, Yoshida N, et al. Prospective validation of optimal drain management “The 3 x 3 Rule” after liver resection. World J Surg 2016; 40:2213–2220.
Donadon M, Costa G, Cimino M, et al. Diagnosis and management of bile leaks after hepatectomy: results of a prospective analysis of 475 hepatectomies. World J Surg 2016; 40:172–181.

Auteurs

Junichi Arita (J)

Hepato-Biliary and Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.

Kentaro Sakamaki (K)

Center for Data Science, Yokohama City University, Yokohama, Japan.

Akio Saiura (A)

Department of Gastrointestinal Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.

Masaru Konishi (M)

Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital East, Chiba, Japan.

Yoshihiro Sakamoto (Y)

Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Kyorin University School of Medicine, Tokyo, Japan.

Masaji Hashimoto (M)

Hepato-Biliary-Pancreatic Surgery Division, Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, Japan.

Tsuyoshi Sano (T)

Department of Surgery, Division of Gastroenterological Surgery, Aichi Medical University, Nagakute, Japan.

Katsuhiko Uesaka (K)

Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, Shizuoka, Japan.

Norihiro Kokudo (N)

National Center for Global Health and Medicine, Tokyo, Japan.

Takeharu Yamanaka (T)

Department of Biostatistics, School of Medicine, Yokohama City University, Yokohama, Japan.

Kazuaki Shimada (K)

Hepatobiliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH